| |
| |
|
| Insider
Information: |
Kingsley Alfred D |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,968,356 |
|
|
Indirect Shares
|
1,512,809 |
|
|
| Direct
Value |
$5,137,134 |
|
|
|
Indirect Value
|
$1,323,637 |
|
|
| Total
Shares |
7,481,165 |
|
|
| Total
Value |
$6,460,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
3.0
|
| Percentage
Gain/Loss : |
 -38.5%
|
 148.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2021-06-22 |
5,470,245 |
2021-06-22 |
1,418,697 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
Director |
2016-06-09 |
9,000 |
2015-06-25 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
Director |
2023-06-23 |
489,111 |
2023-06-23 |
94,112 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LCTX |
Lineage Cell Therapeutics... |
officerTitle |
– – – |
2005-12-21 |
4 |
OE |
$0.40 |
$534,778 |
D/D |
1,336,946 |
4,261,189 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2010-11-01 |
4 |
OE |
$2.00 |
$2,074,116 |
D/D |
1,037,058 |
7,402,394 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2010-08-18 |
4 |
OE |
$1.82 |
$1,818,000 |
D/D |
1,000,000 |
5,918,332 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-02-05 |
5 |
A |
$1.40 |
$818,181 |
D/D |
584,415 |
2,864,243 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2010-10-21 |
4 |
OE |
$2.00 |
$894,008 |
D/D |
447,004 |
6,365,336 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-01-21 |
4/A |
OE |
$1.40 |
$547,567 |
D/D |
391,119 |
2,279,828 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-01-21 |
4/A |
OE |
$1.40 |
$544,662 |
D/D |
389,044 |
2,277,753 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-03-31 |
4 |
A |
$0.00 |
$0 |
I/I |
360,000 |
587,942 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2012-11-15 |
4 |
S |
$2.90 |
$1,000,001 |
D/D |
(344,828) |
7,167,566 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2013-06-04 |
4 |
S |
$0.00 |
$0 |
D/D |
(320,000) |
6,620,055 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2014-05-08 |
4 |
S |
$2.44 |
$730,500 |
D/D |
(300,000) |
6,288,055 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2014-05-16 |
4 |
S |
$2.45 |
$735,000 |
D/D |
(300,000) |
5,988,055 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2016-01-20 |
4 |
S |
$2.35 |
$705,000 |
D/D |
(300,000) |
5,638,055 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • – |
2017-08-17 |
4 |
D |
$2.81 |
$843,000 |
D/D |
(300,000) |
5,481,555 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-01-21 |
4 |
OE |
$1.40 |
$363,108 |
D/D |
259,363 |
2,148,072 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-12-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(248,082) |
350,265 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • – |
2017-01-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(238,469) |
1,143,346 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • – |
2017-01-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(238,469) |
1,143,346 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2013-03-28 |
4 |
S |
$3.81 |
$762,000 |
D/D |
(200,000) |
7,090,055 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-12-31 |
4/A |
D |
$0.00 |
$0 |
I/I |
(191,163) |
407,184 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2012-10-25 |
5 |
A |
$0.00 |
$0 |
D/D |
180,000 |
7,290,055 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-05-05 |
4 |
B |
$0.28 |
$48,625 |
D/D |
175,000 |
4,469,522 |
2.44 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • – |
2017-07-31 |
4 |
S |
$2.80 |
$420,000 |
D/D |
(150,000) |
5,781,555 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
• • • |
2012-07-30 |
4 |
D |
$4.77 |
$667,254 |
D/D |
(140,000) |
7,512,394 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2010-12-01 |
5 |
A |
$0.00 |
$0 |
D/D |
100,000 |
7,502,394 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
